Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia

NCT01905943

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital Iturraspe Santa Fe, Argentina
  • Hospital Erasme; Neurologie Brussels, Belgium
  • Cliniques Universitaires St-Luc Brussels, Belgium
  • Jessa Zkh (Campus Virga Jesse) Hasselt, Belgium
View all 174 locations
View Trial Details
Completed

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

NCT03357471

Conditions
Active Ankylosing Spondylitis, Active Psoriatic Arthritis, Hemic and Lymphatic Diseases, +11 more
Locations
  • Ra0098 116 Mesa, Arizona, United States
  • Ra0098 107 Mesa, Arizona, United States
  • Ra0098 135 Phoenix, Arizona, United States
  • Ra0098 119 Tucson, Arizona, United States
View all 22 locations
View Trial Details
Completed

Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine

NCT01392079

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • Hanuschkrankenhaus Wien Vienna, Austria
  • University Hospital Vienna, Austria
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • Hopital Avicenne Bobigny, France
View all 38 locations
View Trial Details

Related conditions